“Psychedelics crosscut so many interesting domains. They've been used for time immemorial by indigenous cultures. In our own Western cultural history, they really exploded on the scene in the 1960s, and were associated with radical changes to society.”

Biologist Tyler Volk PhD, psychiatrist Bruce Greyson MD, and palliative care physician BJ Miller MD, reveal how confronting mortality can improve the way we live.

Psychiatrist Dr. Bessel van der Kolk discusses key methods for rewiring the brain, kickstarting the healing process, and opening your mind to new perspectives.

An argument for emphasis on subjective experience.

Uncovering the story of Milan Hausner, the Sadská clinic, and LSD psychotherapy behind the Iron Curtain.

One dose of ibogaine was shown to dramatically reduce depression and PTSD.

Some neuroscientists question whether the body can “keep score” of anything in a meaningful way.

Acclaimed psychiatrist Bessel van der Kolk, author of “The Body Keeps The Score,” discusses the widespread existence of trauma and how it settles in our bodies.

The benefits of the psychedelic seem to last long after the trip wears off.

For people with hard-to-treat depression, a non-invasive technique called transcranial magnetic stimulation (TMS) can provide relief.

Jung thought these autonomous entities live in your unconscious mind — often at a cost.

A brief look at the six-decade challenge to psychiatry.

It could explain why so many people don’t respond to common antidepressants.

Johns Hopkins professor Dr. Matthew Johnson answers 24 huge questions about psychedelics.

Desperate times call for desperate measures.

Ketamine-assisted psychotherapy utilizes a non-ordinary state of consciousness to heal.

End of life patients face mental health challenges uniquely existential and spiritual in nature — but psychedelics are emerging as a possible solution to relieve the suffering.

A blood test to diagnose mental illness is a "holy grail" of psychiatry.

New research shows psychedelics activate receptors inside brain cells that other compounds, like serotonin, cannot.

The initial study lays the groundwork for another larger, longer phase 2 trial.

Our society is in a mental health crisis. Are psychedelics the way out?

The real risks of psychedelics, explained by a Johns Hopkins expert.

Terrified of blushing? You might have erythrophobia.

A long-maligned treatment outperforms the trendy one.

Psychedelic medicines are surging in popularity. Here’s how they work.

Antidepressants can help alleviate PTSD symptoms when paired with psychotherapy, but does our overenthusiasm for them blind us to more effective alternatives?

When other treatments fail, this radical surgery could help.

A key question is how to keep that relief going without relying solely on repeated ketamine infusions.

While one may be helpful, the other may be harmful.

The serotonin theory of depression started to be widely promoted in the 1990s, coinciding with a push to prescribe more SSRIs.